Skip to search.
 NZX 50 Up 0.64%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
5.78 Up 0.07(1.23%) 04:08 - Nasdaq Real Time Price
Prev Close:5.71
Open:5.77
Bid:5.75 x 600
Ask:5.76 x 800
1y Target Est:8.15
Beta:3.04503
Earnings Date:3 Aug - 8 Aug (Est.)
Day's Range:5.70 - 5.86
52wk Range:2.80 - 10.80
Volume:419,033
Avg Vol (3m):1,756,880
Market Cap:611.65m
P/E (ttm):N/A
EPS (ttm):-1.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KERXUp 1.23%611.65m
BAXDown 0.05%23.97b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):31.26
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.96
Quarterly EPS Est (Jun-16) :-0.27
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-0.05

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback